Taken together, these findings suggest that P3 and P4 peptides regulate cholesterol metabolism during oxLDL-induced foam cell formation by activating the PPAR-γ/LXR-α signaling axis, thereby enhancing cholesterol efflux and potentially mitigating the development of atherosclerosis. The gene discussed is PPARG; the disease is atherosclerosis.